BACKGROUND
Newswise — Mesenchymal stem cells (MSCs), as a living bio-drug, are being considered as a potential treatment for coronavirus disease 2019 (COVID-19)-induced acute respiratory distress syndrome (ARDS) due…
Living Bio-Drug Therapies Using Mesenchymal Stem Cells and Exosomes for Mechanically Ventilated Patients with Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis
